Chart Analysis
AI1 Daily Timeframe Chart as of 23 April 2026
Adisyn (ASX: AI1) Raises A$14M Cornerstoned by Regal and Meitav After Back-to-Back Graphene Breakthroughs in Semiconductors and Stealth Drone Technology
Two institutional investors managing a combined A$210 billion — Regal Funds Management and Israel's Meitav — have cornerstoned a A$14 million placement at A$0.0675 per share for a company that reported A$3.48 million in revenue and A$9.6 million in net losses last year. The capital validates two technology milestones announced in the same week: a graphene semiconductor interconnect breakthrough (the first to achieve continuous graphene formation at fab-compatible temperatures on an industrial ALD system) and an exclusive worldwide licence from Tel Aviv University for graphene-based radar absorption technology targeting stealth drones. The stock moved +80% to $0.135 on 23 April 2026 — trading at a 100% premium to the placement price — with no SPP announced for retail shareholders.
The Two Technology Milestones That Preceded the Raise
Semiconductor interconnects (20 April 2026): Through subsidiary 2D Generation, Adisyn demonstrated graphene formation at semiconductor-compatible temperatures (~450°C) using an industrial Atomic Layer Deposition system — simultaneously achieving three criteria the industry has been unable to combine until now. Copper interconnects are widely regarded as one of the most critical bottlenecks constraining chip performance below 2nm nodes. The global semiconductor industry is forecast to reach approximately US$1 trillion by 2030.
Stealth drone technology (22 April 2026): Subsidiary 2D Radar Absorbers secured an exclusive worldwide licence from Ramot (Tel Aviv University's technology transfer company) for graphene-based radar absorption. Lab testing has demonstrated approximately 20dB radar absorption (100-fold reduction in radar return), with optimisation targeting 30dB (1,000-fold). The structured 12-month research program costs less than A$100,000. The global military drone market is projected to reach US$66.5 billion by 2035.
The Placement — Who's In and What They Paid
| Detail | Value |
|---|---|
| Raise Amount | A$14,000,000 |
| Issue Price | A$0.0675 (10% discount to last close, 5.78% to 15-day VWAP) |
| New Shares | ~207.4 million (~24.9% increase in share count) |
| Cornerstones | Regal Funds Management (A$20B+ AUM), Meitav (~A$190B AUM) |
| Director Participation | A$200,000 (Kevin Crofton + Dominic O'Hanlon, subject to approval) |
| Lead Manager | Sandton Capital Advisory (6% fee, ~A$840K) |
| Settlement | 29 April 2026 |
Proceeds fund graphene technology advancement (lab-to-wafer scale-up for semis, radar absorption R&D), business development with semiconductor and defence partners, and working capital. No specific dollar breakdown was provided. No SPP has been announced — retail investors cannot participate at the $0.0675 placement price.
Risks & Considerations
Both technology programs are pre-revenue with no commercial agreements or binding offtake. The semiconductor program has demonstrated graphene formation on a 1cm² coupon — scaling to full wafer-level manufacturing involves significant technical hurdles in repeatability, yield, and fab integration that are unproven. The radar absorption program is a 12-month research effort with no product or customer engagement.
FY2025 revenue declined 50.5% to A$3.48 million against net losses of A$9.6 million. The A$14 million raise provides near-term runway, but at the current burn rate further capital may be needed if milestones extend. The ~24.9% share count increase is material dilution, and the 6% lead manager fee (~A$840K) consumes a meaningful portion of the raise for a company with limited revenue.
The stock traded at a 100% premium to the placement price on announcement day — meaning the market is pricing both technology milestones at double what institutional investors paid just days earlier. Whether this premium is sustained will depend on progress from lab demonstration toward commercial engagement.
Key Dates & Timeline
| Date | Event |
|---|---|
| 20 April 2026 | Graphene semiconductor breakthrough announced |
| 22 April 2026 | Stealth drone technology licence announced |
| 23 April 2026 | A$14M placement announced; share price moved +80% |
| 29–30 April 2026 | New share settlement and allotment |
| ~June 2026 | General meeting for director participation approval |
Price Data
- Previous Close: $0.075
- Close Price (23 April 2026): $0.135
- Change (23 April 2026): +80.0%
- 52-Week Range: $0.038 – $0.145
Notable Price Levels
-
$0.145 — 52-week high and intraday high on announcement day. The stock closed at $0.135 after testing $0.145, with only a 6.9% pullback from the session peak — a relatively tight intraday fade indicating limited selling pressure at the high. No historical overhead supply exists above this level.
-
$0.0675 — placement price at which ~207.4 million shares were issued to Regal, Meitav, and other institutional investors. This is the most structurally significant level — a 50% discount to the announcement-day close. Below $0.0675, all placement participants are underwater and the institutional thesis is challenged.
-
$0.075 — undisturbed close and the bottom of the gap-up window. A full retracement here would unwind the entire announcement premium. The stock had been consolidating at $0.070–$0.080 before the trading halt.
-
$0.038 — 52-week low. A return here would reverse the entire 2025–2026 re-rating including the graphene breakthroughs and institutional placement, pricing AI1 back to its most pessimistic valuation.
Summary
Adisyn raised A$14 million at A$0.0675 per share through an institutional placement cornerstoned by Regal Funds Management and Meitav (combined AUM exceeding A$210 billion), following back-to-back technology milestones in graphene semiconductor interconnects and stealth drone radar absorption. The stock moved +80% to $0.135 on 23 April 2026 — a 100% premium to the placement price. Both programs are pre-revenue: the semiconductor breakthrough demonstrated graphene formation on a 1cm² coupon at fab-compatible temperatures, while the radar absorption licence from Tel Aviv University is a 12-month research program costing less than A$100,000. FY2025 revenue was A$3.48 million (down 50.5%) against losses of A$9.6 million. The ~24.9% dilution comes with no SPP for retail shareholders.
This article is for informational purposes only and does not constitute financial advice. Market Flow does not recommend buying or selling any securities. Past performance is not indicative of future results. Readers should conduct their own independent research and consult a licensed financial adviser before making any investment decisions. This content is published in accordance with ASX Market Rules and is not a financial product recommendation.